Literature DB >> 1334764

Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons.

S J Tallaksen-Greene1, R G Wiley, R L Albin.   

Abstract

Quantitative autoradiography was used to examine the cellular localization of excitatory amino acid binding sites in the striatum following selective lesion of striatonigral projection neurons. Degeneration of striatonigral neurons was induced unilaterally by injection of the suicide transport toxin, volkensin, into the left substantia nigra. Twelve days following nigral volkensin injection there was a reduction of all excitatory amino acid binding site subtypes in the striatum ipsilateral to the injected nigra. The reduction in N-methyl-D-aspartate (NMDA) binding sites was significantly greater than the loss of D,L-alpha-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid (AMPA), kainate and metabotropic binding. These results indicate that there are NMDA, AMPA, metabotropic and kainate binding sites on striatonigral projection neurons and suggest that the NMDA subtype may be selectively enriched on striatonigral neurons.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334764     DOI: 10.1016/0006-8993(92)91044-f

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Rearrangement of neuronal interactions upon activation of different glutamate receptors.

Authors:  T L Dyakonova
Journal:  Dokl Biol Sci       Date:  2003 Jan-Feb

2.  Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core.

Authors:  A E Kelley; S L Smith-Roe; M R Holahan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat.

Authors:  V Bernard; P Somogyi; J P Bolam
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

4.  Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study.

Authors:  K Ossowska; M Pietraszek; J Wardas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

5.  Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats.

Authors:  Maowen Ba; Min Kong; Hongqi Yang; Guozhao Ma; Guoqiang Lu; Shengdi Chen; Zhenguo Liu
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

6.  Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions.

Authors:  C S Maldonado-Irizarry; A E Kelley
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

7.  Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis.

Authors:  Z B You; A Saria; R Fischer-Colbrie; L Terenius; M Goiny; M Herrera-Marschitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

8.  Glutamate controls growth rate and branching of dopaminergic axons.

Authors:  Yvonne Schmitz; James Luccarelli; Minji Kim; Mi Wang; David Sulzer
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

Review 9.  Glutamate and Parkinson's disease.

Authors:  F Blandini; R H Porter; J T Greenamyre
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.